BP862

Quinine hemisulfate salt dihydrate

British Pharmacopoeia (BP) Reference Standard

• Sinônimo(s): (8α,9R)- 6′-Methoxycinchonan-9-ol sulfate, hydrate (2:1:4)
• Fórmula empírica (Notação de Hill): C₂₀H₂₄N₂O₂ · 0.5H₂O₄S · 2H₂O
• Número CAS: 6119-70-6
• Peso molecular: 409.49
• Número MDL: MFCD00150790
• Código UNSPSC: 41116107
• NACRES: NA.24

Propriedades

• grau: pharmaceutical primary standard
• família API: quinine
• Formulário: powder
• prazo de validade: limited shelf life, expiry date on the label
• fabricante/nome comercial: BP
• aplicação(ões): pharmaceutical; pharmaceutical small molecule
• Formato: neat
• temperatura de armazenamento: 2-8°C
• cadeia de caracteres SMILES: [S](=O)(=O)(O)O.N65[C@@H](CC([C@H](C6)C=C)CC5)[C@H](O)c7c8c(ncc7)ccc(c8)OC.N21[C@@H](CC([C@H](C2)C=C)CC1)[C@H](O)c3c4c(ncc3)ccc(c4)OC.O.O
• InChI: 1S/2C20H24N2O2.H2O4S.2H2O/c2*1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18;1-5(2,3)4;;/h2*3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H3;(H2,1,2,3,4);2*1H2/t2*13-,14?,19-,20+;;;/m00.../s1
• chave InChI: ZHNFLHYOFXQIOW-LRXYSQQVSA-N

Descrição

Descrição geral

This product is provided as delivered and specified by the issuing Pharmacopoeia. All information provided in support of this product, including SDS and any product information leaflets have been developed and issued under the Authority of the issuing Pharmacopoeia. For further information and support please go to the website of the issuing Pharmacopoeia.

Aplicação

Quinine hemisulfate salt dihydrate BP Reference standard, intended for use in laboratory tests only as specifically prescribed in the British Pharmacopoeia.

Also used in monographs such as:

Ticarcillin and Clavulanic Acid Infusion

Co-amoxiclav Injection

Co-amoxiclav Tablets

Co-amoxiclav Oral Suspension

Co-amoxiclav Dispersible Tablets

Quinine Sulfate Tablets

Quinine Bisulfate

Quinine Dihydrochloride Infusion

Quinine Bisulfate Tablets

Quinine Sulfate Oral Suspension

Quinine Dihydrochloride

Quinidine Sulfate Tablets

Embalagem

Unit quantity: 300 mg. Subject to change. The product is delivered as supplied by the issuing Pharmacopoeia. For the current unit quantity please visit British Pharmacopoeia

Outras notas

Sales restrictions may apply.

Informações de segurança

• Pictogramas: GHS07
• Palavra indicadora: Warning
• Frases de perigo: H315,H319,H335
• Declarações de precaução: P302 + P352 - P305 + P351 + P338
• Classificações de perigo: Eye Irrit. 2 - Skin Irrit. 2 - STOT SE 3
• Órgãos-alvo: Respiratory system
• Código de classe de armazenamento: 11 - Combustible Solids
• Classe de risco de água (WGK): WGK 1
• Ponto de fulgor (°F): Not applicable
• Ponto de fulgor (°C): Not applicable